431 related articles for article (PubMed ID: 34512145)
1. Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network.
Hao A; Wang Y; Stovall DB; Wang Y; Sui G
Int J Biol Sci; 2021; 17(13):3268-3280. PubMed ID: 34512145
[TBL] [Abstract][Full Text] [Related]
2. EZH2 RIP-seq Identifies Tissue-specific Long Non-coding RNAs.
Wang Y; Xie Y; Li L; He Y; Zheng D; Yu P; Yu L; Tang L; Wang Y; Wang Z
Curr Gene Ther; 2018; 18(5):275-285. PubMed ID: 30295189
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
Chen XJ; An N
J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896
[TBL] [Abstract][Full Text] [Related]
4. EZH2-interacting lncRNAs contribute to gastric tumorigenesis; a review on the mechanisms of action.
Mohebbi H; Esbati R; Hamid RA; Akhavanfar R; Radi UK; Siri G; Yazdani O
Mol Biol Rep; 2024 Feb; 51(1):334. PubMed ID: 38393645
[TBL] [Abstract][Full Text] [Related]
5. Non-coding RNAs-EZH2 regulatory mechanisms in cervical cancer: The current state of knowledge.
Zheng J; Chen L
Biomed Pharmacother; 2022 Feb; 146():112123. PubMed ID: 34915417
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
[TBL] [Abstract][Full Text] [Related]
7. Noncanonical Functions of the Polycomb Group Protein EZH2 in Breast Cancer.
Anwar T; Gonzalez ME; Kleer CG
Am J Pathol; 2021 May; 191(5):774-783. PubMed ID: 33556366
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody raised against human EZH2 cross-reacts with the RNA-binding protein SAFB.
Cherney RE; Mills CA; Herring LE; Braceros AK; Calabrese JM
Biol Open; 2023 Jun; 12(6):. PubMed ID: 37283223
[TBL] [Abstract][Full Text] [Related]
9. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
10. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
Au SL; Wong CC; Lee JM; Wong CM; Ng IO
PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
[TBL] [Abstract][Full Text] [Related]
11. EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?
Yan KS; Lin CY; Liao TW; Peng CM; Lee SC; Liu YJ; Chan WP; Chou RH
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561778
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of enhancer of zeste homolog 2 (EZH2) -Yin Yang 1 (YY1) axis in cancer.
Chandnani N; Gupta I; Thakkar V; Sarkar K
Pathol Res Pract; 2023 Nov; 251():154885. PubMed ID: 37862922
[TBL] [Abstract][Full Text] [Related]
13. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
[TBL] [Abstract][Full Text] [Related]
14. Cryptic RNA-binding by PRC2 components EZH2 and SUZ12.
Betancur JG; Tomari Y
RNA Biol; 2015; 12(9):959-65. PubMed ID: 26177152
[TBL] [Abstract][Full Text] [Related]
15. The noncanonical role of EZH2 in cancer.
Huang J; Gou H; Yao J; Yi K; Jin Z; Matsuoka M; Zhao T
Cancer Sci; 2021 Apr; 112(4):1376-1382. PubMed ID: 33615636
[TBL] [Abstract][Full Text] [Related]
16. Regulation and Role of EZH2 in Cancer.
Yamaguchi H; Hung MC
Cancer Res Treat; 2014 Jul; 46(3):209-22. PubMed ID: 25038756
[TBL] [Abstract][Full Text] [Related]
17. Ppp1r1b-lncRNA inhibits PRC2 at myogenic regulatory genes to promote cardiac and skeletal muscle development in mouse and human.
Kang X; Zhao Y; Van Arsdell G; Nelson SF; Touma M
RNA; 2020 Apr; 26(4):481-491. PubMed ID: 31953255
[TBL] [Abstract][Full Text] [Related]
18. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX
Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960
[TBL] [Abstract][Full Text] [Related]
19. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation.
Mu W; Starmer J; Yee D; Magnuson T
Epigenetics Chromatin; 2018 Dec; 11(1):71. PubMed ID: 30522506
[TBL] [Abstract][Full Text] [Related]
20. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p.
Qin WX; Shi Y; Zhu D; Li YP; Chen YH; Cui J; Cui GY; Pan JX; Ren ZY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3204-3214. PubMed ID: 32271438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
